Simulation-based training improves fundus identification success in ophthalmology education
Simulation training improves eye exam skills in early review
This systematic review and meta-analysis of 772 participants found that simulation-based training led to a 63.1% fundus identification succe…
A review of 772 participants found simulation training helped identify eye structures better than traditional methods, with most preferring …
Netarsudil plus latanoprost cuts diurnal IOP 2.36 mmHg vs latanoprost alone in Japanese glaucoma
Adding netarsudil to latanoprost lowers eye pressure faster in Japanese patients with glaucoma
This Phase III randomized controlled trial in 246 Japanese participants with primary open-angle glaucoma or ocular hypertension found that n…
Japanese patients with glaucoma saw lower eye pressure when adding netarsudil to their current latanoprost drops compared to a placebo plus …
Rho-kinase inhibitors reduce intraocular pressure by 9.32 mmHg at 3 months in uveitic glaucoma patients
Rho-kinase inhibitors lower eye pressure in uveitic glaucoma patients
This systematic review and meta-analysis evaluated Rho-kinase inhibitors for uveitic glaucoma or ocular hypertension secondary to uveitis. T…
A meta-analysis of 383 participants found Rho-kinase inhibitors significantly reduce eye pressure in uveitic glaucoma with a favorable safet…
Perioperative anti-VEGF injections improve vision and reduce bleeding in proliferative diabetic retinopathy
Anti-VEGF injections before eye surgery improve vision and reduce bleeding in diabetic retinopathy
This network meta-analysis evaluated the timing of perioperative anti-VEGF injections for proliferative diabetic retinopathy. Results indica…
A network meta-analysis of 2,646 eyes found that perioperative anti-VEGF injections improved vision and reduced bleeding in patients with pr…
Baseline disc hemorrhage strongly predicts progression in primary open-angle and normal tension glaucoma
Disc hemorrhage predicts faster vision loss in glaucoma patients
This systematic review and meta-analysis of 22 papers found that baseline disc hemorrhage is associated with progression in primary open-ang…
A blood spot on the optic nerve signals a higher risk of disease progression in patients with primary open-angle or normal tension glaucoma.
Ethambutol optic neuropathy incidence 1.54 percent with renal impairment and hypertension as key risk factors
Kidney disease and high blood pressure raise risk of vision loss from TB drug
This systematic review and meta-analysis synthesized evidence on ethambutol optic neuropathy and tuberculous meningitis complications. The p…
A massive review of over 260,000 patients found that kidney problems and high blood pressure make vision loss from the TB drug ethambutol mu…
GWAS meta-analysis identifies 10 CSC loci and links genetic risk to OCT abnormalities
Genetic clues point to new pathways for Central Serous Chorioretinopathy
This meta-analysis of GWAS data from European-ancestry cohorts identified 10 genome-wide significant loci for central serous chorioretinopat…
A massive genetic study finds specific DNA spots linked to Central Serous Chorioretinopathy, offering new targets for future treatment resea…
Case report and review of literature on acute NSTEMI after fluorescein angiography in a 76-year-old woman
Rare heart attack possible after fluorescein angiography in older adults with heart disease
This case report and review of the literature describes a 76-year-old woman with hypertension, hyperlipidemia, and type 2 diabetes mellitus …
A 76-year-old woman with heart disease had a heart attack shortly after a dye test, highlighting rare risks.
Narrative review outlines risk stratification and selective intervention for peripheral retinal degenerations
New imaging helps doctors decide when to treat risky eye spots before tears form
This narrative review synthesizes evidence from 29 studies regarding the management of peripheral retinal degenerations. The authors propose…
A review of 29 studies shows how better imaging and AI can help doctors decide when to treat risky eye spots before tears form.
Netarsudil shows lower IOP reduction but better conjunctival hyperemia profile versus prostaglandin analogues
New data shows netarsudil offers a safer option for some glaucoma patients
A Bayesian network meta-analysis found netarsudil ranked lower for IOP reduction but had a more favorable conjunctival hyperemia profile com…
A fresh look at glaucoma drugs shows one option causes less redness while still helping lower eye pressure effectively.
Narrative review of injectable corneal endothelial cell therapy for Fuchs endothelial corneal dystrophy and pseudophakic bullous keratopathy
Millions With Cloudy Vision May Skip Corneal Transplant Surgery Soon
This narrative review examines pre-clinical and clinical data on injectable corneal endothelial cell (CEC) therapy for Fuchs endothelial cor…
• A simple eye injection restores clear vision without surgery • Helps people with Fuchs dystrophy or post-cataract swelling • Still in tria…
FDA Approves Pavblu (aflibercept) for Neovascular AMD, RVO, DME, and DR
FDA approves Pavblu to treat several eye conditions that cause vision loss.
The FDA approved Pavblu (aflibercept) for neovascular AMD, macular edema following RVO, DME, and DR. It is a VEGF inhibitor administered by …
The FDA approved Pavblu (aflibercept) for wet age-related macular degeneration, macular edema, diabetic macular edema, and diabetic retinopa…